Student Academy of Audiology

Advocacy in Audiology Virtual Session
2021-06-22 20:00 - 21:00 (America/New_York)
Session Abstract: This advocacy presentation will provide attendees with the latest updates on federal legislative and regulatory issues impacting the profession of audiology. Some of the topics covered will include the latest prognosis on the Medicare Audiologist Access and Services Act (the joint audiology bill), the ongoing debate regarding Medicare expansion to include hearing, vision, and dental services, and the status of OTC hearing aid regulations. This presentation will also provide an update on the Audiology and Speech-Language Pathology Interstate Licensure Compact (ASLP-IC) as well as other high-impact legislation that was considered in the states earlier this year pertaining to hearing aids, audiology assistants, and board structure.
Speaker: Susan Pilch, JD, Senior Director of Government Relations for the American Academy of Audiology
Registration is required for this event. Fill out the registration form by Saturday, June 19, 2021.
Interested in learning more about the Academy’s advocacy efforts? Visit the Academy’s Legislative Action Center to learn about legislative priorities and read up on all the latest government relations news!
Susan currently serves as the Senior Director of Government Relations for the American Academy of Audiology and oversees federal and state legislative and regulatory efforts. Over the course of her career, Susan has represented numerous participants in the healthcare system—both at the state and federal level including speech-language pathologists/audiologists, pharmaceutical wholesalers, community pharmacies and hospitals. As a result of this experience, she has significant experience on a wide range of issues including state licensure, reimbursement, contractual and policy-related insurance coverage issues, Medicare and Medicaid and patient access to services and care. In addition, Susan has worked extensively with public and commercial payers as well as with patient advocacy groups and industry partners.
